首页 课程 直播 学堂
登录|注册
陆舜:精准肿瘤学时代基于组织标本的肺癌临床研究
关注
相关课程
课程介绍
Personalized medicine may be defined as “a medical model using molecular profiling technologies for tailoring the right therapeutic strategy for the right person at the right time, and determine the predisposition to disease at the population level and to deliver timely and stratified prevention”. Progress in the understanding of driven genes and drug actions are opening opportunities to match therapies to lung cancer patient populations, and thus pave the way towards a more personalized medicine. The use of driven genes such as EGFR, ALK, and ROS1 et al can help identify patients that are more likely to respond favorably to a given therapy which is approved by clinical trials. Increasingly, we find application in order to stratify different patient groups in terms of clinical response, so as to develop personalized, preventive or therapeutic strategies.
我要咨询
讲师介绍
  • 讲师:陆舜(主任医师、教授)

    上海交通大学附属胸科医院教授,临床医学博士,主任医师,博士研究生导师。上海市肺部肿瘤临床医学中心主任。目前参加和承担国家和上海市科研基金项目8项。其中国家级课题为:2007年与2012年均作为第1负责人承担国家863重大课题“肺癌的分子分型和个体化诊疗”的子课题;2007年参与承担国家十一五科技支撑计划课题,2012年作为第一负责人承担科技部国际合作课题“中瑞合作肺癌临床医学中心肺癌诊治关键技术转化医学研究”。还承担上海市科委课题3项,上海市卫生局申康医院发展中心课题共2项。